Skip to main content

Nemes Rush Group LLC

SEC CIK
0001982273
Latest filing
Aug 14, 2026

BLRX holding history

BioLineRx Ltd. in every 13F filed by Nemes Rush Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BLRX overviewAll 13F holders of BLRXFull Q2 2026 holdings

Shares (Q2 2026)
250
Value
$780
% of portfolio
<0.1%
Quarters held
13
Since Q2 2023
Holdings of BLRX by Nemes Rush Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026250$780<0.1%00.0%UnchangedHolders
Q1 2026250$575<0.1%00.0%UnchangedHolders
Q4 2025250$693<0.1%00.0%UnchangedHolders
Q3 2025250$945<0.1%00.0%UnchangedHolders
Q2 2025250$1.14K<0.1%−50−16.7%ReducedHolders
Q1 2025300$888<0.1%00.0%UnchangedConverted for a 1-for-40 splitHolders
Q4 202412,000$2.57K<0.1%00.0%UnchangedHolders
Q3 202412,000$13.4K<0.1%00.0%UnchangedHolders
Q2 202412,000$6.84K<0.1%00.0%UnchangedHolders
Q1 202412,000$13.4K<0.1%00.0%UnchangedHolders
Q4 202312,000$18.8K<0.1%00.0%UnchangedHolders
Q3 202312,000$21.8K<0.1%00.0%UnchangedHolders
Q2 202312,000$19.1K<0.1%–No prior filingHolders